WO2003049687A3 - Compositions medicinales et methodes therapeutiques - Google Patents

Compositions medicinales et methodes therapeutiques Download PDF

Info

Publication number
WO2003049687A3
WO2003049687A3 PCT/US2002/038898 US0238898W WO03049687A3 WO 2003049687 A3 WO2003049687 A3 WO 2003049687A3 US 0238898 W US0238898 W US 0238898W WO 03049687 A3 WO03049687 A3 WO 03049687A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic methods
medicinal compositions
compositions
food supplement
dietary food
Prior art date
Application number
PCT/US2002/038898
Other languages
English (en)
Other versions
WO2003049687A2 (fr
Inventor
Seymour Ehrenpreis
Lawrence Howard
Original Assignee
Weller Health Inc
Seymour Ehrenpreis
Lawrence Howard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weller Health Inc, Seymour Ehrenpreis, Lawrence Howard filed Critical Weller Health Inc
Priority to US10/497,631 priority Critical patent/US20040241256A1/en
Priority to AU2002359618A priority patent/AU2002359618A1/en
Publication of WO2003049687A2 publication Critical patent/WO2003049687A2/fr
Publication of WO2003049687A3 publication Critical patent/WO2003049687A3/fr
Priority to US11/479,216 priority patent/US20060252727A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Les compositions de l'invention comprennent un mélange: 1) de phénylalanine et d'un complément alimentaire; 2) de leucine et d'un complément alimentaire; et 3) d'acide hydrocinnamique et d'un complément alimentaire. Les compositions de l'invention sont utilisées à des fins médicinales pour soulager diverses maladies.
PCT/US2002/038898 2001-12-06 2002-12-05 Compositions medicinales et methodes therapeutiques WO2003049687A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/497,631 US20040241256A1 (en) 2002-12-05 2002-12-05 Medicinal compositions & therapeutic methods
AU2002359618A AU2002359618A1 (en) 2001-12-06 2002-12-05 Medicinal compositions and therapeutic methods
US11/479,216 US20060252727A1 (en) 2001-12-06 2006-06-30 Medicinal compositions and therapeutic methods for treating arthritis and other painful conditions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33832001P 2001-12-06 2001-12-06
US60/338,320 2001-12-06

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/479,216 Continuation US20060252727A1 (en) 2001-12-06 2006-06-30 Medicinal compositions and therapeutic methods for treating arthritis and other painful conditions

Publications (2)

Publication Number Publication Date
WO2003049687A2 WO2003049687A2 (fr) 2003-06-19
WO2003049687A3 true WO2003049687A3 (fr) 2005-12-22

Family

ID=23324320

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038898 WO2003049687A2 (fr) 2001-12-06 2002-12-05 Compositions medicinales et methodes therapeutiques

Country Status (2)

Country Link
AU (1) AU2002359618A1 (fr)
WO (1) WO2003049687A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7071754B2 (ja) 2020-07-28 2022-05-19 株式会社東洋新薬 関節機能改善組成物

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1708301A (zh) 2002-10-30 2005-12-14 Asat应用科学技术股份公司 褪黑激素日剂量给药单元
US20050037983A1 (en) * 2003-03-11 2005-02-17 Timothy Dinan Compositions and methods for the treatment of depression and other affective disorders
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
PL371081A1 (pl) * 2004-11-08 2006-05-15 Sgp & Sons Ab Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt
EP2175273B1 (fr) 2005-11-09 2013-09-04 Ajinomoto Co., Inc. Agent d'accord kokumi
EP1945201B1 (fr) 2005-11-09 2011-09-28 Ajinomoto Co., Inc. Activateur du recepteur du calcium
US8420144B2 (en) 2005-11-09 2013-04-16 Ajinomoto Co., Inc. Kokumi-imparting agent, method of using, and compositions containing same
NZ581627A (en) 2007-05-08 2012-07-27 Ajinomoto Kk Low fat food with a calcium receptor activating additive
US20110039928A1 (en) * 2009-08-13 2011-02-17 Golini Jeffrey M Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition
US20130142894A1 (en) * 2011-11-16 2013-06-06 Bimini Llc Health supplement compositions for companion animals and methods of using the same
GB2510374A (en) * 2013-01-31 2014-08-06 Christopher Francis Bennett Formulation comprising N-acetylcarnitine and D-ribose
CN104306564A (zh) * 2014-10-31 2015-01-28 贵州黄平美娘冲民族服饰有限公司 一种治疗神经衰弱的药物组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7071754B2 (ja) 2020-07-28 2022-05-19 株式会社東洋新薬 関節機能改善組成物

Also Published As

Publication number Publication date
AU2002359618A1 (en) 2003-06-23
WO2003049687A2 (fr) 2003-06-19

Similar Documents

Publication Publication Date Title
HUP0401241A3 (en) Novel cyclohexyl sulphones, process for their preparation and pharmaceutical compositions containing them
AU4871797A (en) Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it
AU2002245222A1 (en) Beverage compositions comprising palatable calcium and magnesium sources
WO2005074970A3 (fr) Complément alimentaire neuroprotecteur
WO2003049687A3 (fr) Compositions medicinales et methodes therapeutiques
IL161431A0 (en) beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
WO2000053758A3 (fr) Compositions et methodes de traitement des maladies immunitaires
WO2004043363A8 (fr) Preparations liposomales d'agents pharmaceutiques stabilisees par des proteines
WO2003087050A3 (fr) Sel de perindopril et les compositions pharmaceutiques qui le contiennent
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
WO2000003684A3 (fr) Formulations au soja et utilisation de ces dernieres pour ameliorer la sante
HUP0200292A2 (hu) Táplálék-kompozíció éretlen emlősök számára, speciális gyomor- és bélrendszeri éréshez
WO2002094774A3 (fr) Formes galeniques d'oxcarbazepine
WO2000073452A3 (fr) Compositions et methodes de traitement de maladies liees a l'immunite
WO2003014079A8 (fr) Polymorphe stable de flibanserine, procede de preparation associe et utilisation dudit polymorphe dans la preparation de medicaments
CA2419314A1 (fr) Preparation de risperidone
AU2002331013A1 (en) Calcium dietary supplement
HUP0303006A3 (en) Retinoids for the treatment of emphysema, process for their preparation and pharmaceutical compositions containing them
HUP0400040A2 (hu) Szulfonamidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
AU2002241408A1 (en) Modular system of dietary supplement compositions comprising vitamins
AU2001277940A1 (en) Dietary supplement compositions
AU2001236616A1 (en) Improved stability conjugated linoleic acid composition for dietary supplement and food uses
MXPA02011465A (es) Sal de creatina que tiene eficacia terapeutica y nutricional mejorada y composiciones que contienen la misma.
AU2003205710A1 (en) Use of anti-adhesive packaging materials for packaging chemicals and food
WO2004009085A3 (fr) Comprimes de sumatriptan a gout masque et procedes de fabrication

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10497631

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP